Innova Captab Limited (INNOVACAP) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Innova Captab Limited (INNOVACAP) has a cash flow conversion efficiency ratio of 0.029x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs297.19 Million ≈ $3.21 Million USD) by net assets (Rs10.21 Billion ≈ $110.43 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See INNOVACAP equity to assets ratio to measure how much of total assets are equity-financed.
Innova Captab Limited - Cash Flow Conversion Efficiency Trend (2018–2026)
This chart illustrates how Innova Captab Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Innova Captab Limited to evaluate the quality of earnings relative to operating cash generation.
Innova Captab Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Innova Captab Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
HealthStream Inc
NASDAQ:HSTM
|
0.037x |
|
Cracker Barrel Old Country Store
NASDAQ:CBRL
|
0.221x |
|
Shandong Astro-century Education&Technology Co Ltd
SHE:300654
|
0.023x |
|
ZheJiang RIFA Digital Precision Machinery Co Ltd
SHE:002520
|
0.336x |
|
Ceepower Co Ltd
SHE:300062
|
0.027x |
|
Shinry Technologies Co Ltd Class A
SHE:300745
|
0.150x |
|
APAQ Technology Co Ltd
TW:6449
|
0.048x |
|
MK Restaurant Group Public Company Limited
BK:M
|
0.047x |
Annual Cash Flow Conversion Efficiency for Innova Captab Limited (2018–2026)
The table below shows the annual cash flow conversion efficiency of Innova Captab Limited from 2018 to 2026. For the full company profile with market capitalisation and key ratios, see Innova Captab Limited (INNOVACAP) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs10.91 Billion ≈ $117.97 Million |
Rs1.03 Billion ≈ $11.11 Million |
0.094x | +41.47% |
| 2025-03-31 | Rs9.59 Billion ≈ $103.76 Million |
Rs638.44 Million ≈ $6.90 Million |
0.067x | -62.22% |
| 2024-03-31 | Rs8.31 Billion ≈ $89.86 Million |
Rs1.46 Billion ≈ $15.83 Million |
0.176x | -14.57% |
| 2023-03-31 | Rs3.26 Billion ≈ $35.21 Million |
Rs671.24 Million ≈ $7.26 Million |
0.206x | -26.98% |
| 2022-03-31 | Rs2.09 Billion ≈ $22.56 Million |
Rs588.98 Million ≈ $6.37 Million |
0.282x | +7.15% |
| 2021-03-31 | Rs1.45 Billion ≈ $15.66 Million |
Rs381.60 Million ≈ $4.13 Million |
0.263x | +224.86% |
| 2020-03-31 | Rs3.80 Billion ≈ $41.06 Million |
Rs307.97 Million ≈ $3.33 Million |
0.081x | -86.89% |
| 2019-03-31 | Rs305.11 Million ≈ $3.30 Million |
Rs188.72 Million ≈ $2.04 Million |
0.619x | +138.16% |
| 2018-03-31 | Rs626.18 Million ≈ $6.77 Million |
Rs162.62 Million ≈ $1.76 Million |
0.260x | -- |
About Innova Captab Limited
Innova Captab Limited, an integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs in India and internationally. The company provides contract development and manufacturing organization services to Indian pharmaceutical companies. It is also offers various generic formulation products, including cephalosporins, proton pump inhib… Read more